Recruiting

Observational Study

Sponsor:

UCLA

Code:

NCT04314752

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The objectives of the proposed study are to develop and evaluate protocols for ethnic/racial minority-specific research using cancer registry data. In conjunction with the Cancer Registry of Greater California (CRGC), the investigators have developed procedures to identify, recruit, and survey ethnic/racial minority patients with MM. To pilot the study, the investigators aim initially to test the feasibility of this protocol by contacting 400 eligible patients (100 African Americans, 100 Latinos, 100 Asian American/Native Hawaiian/Pacific Islander-AANHPI and 100 non-Hispanic Whites as a comparison group) to conduct a pilot survey through which will ascertain etiological and survival-related factors for MM. Ultimately, the investigators hope the findings from this pilot will yield insight into the best practices for recruiting minorities with MM and serve as the basis for larger population-based studies of MM etiology and survival.

The next phase of this study is to expand the study to all 3 California Cancer Registries, including the Greater Bay Area Cancer Registry and the Los Angeles Cancer Surveillance Program and Cancer Registry of Greater California. We will increase the sample size to recruit atleast 1000 participants per racial/ethnic group. We will also request to increase the scope of the study to also continue a survivorship cohort.

Conditions

Multiple Myeloma

Study ID

NCT04314752

Start date

Sep 1, 2020

Status verified date

Sep, 2025

Completion date

May 30, 2026

Anticipated

Primary completion date

May 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosed with a first primary pathologically confirmed case of Multiple Myeloma within the previous 5 years
  • At least 21 years of age at the time of diagnosis
  • Must have been diagnosed in one of the 48 counties in California
  • Participant must be alive
  • Identify as one of the following: African American, Latino, Asian American/Native Hawaiian/Pacific Islander, Non-Hispanic White

Exclusion Criteria:

  • People who have not been diagnosed with Multiple Myeloma
  • Under the age of 21
  • Pregnant
  • Prisoner

Study Design

Enrollment

4000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Review the response rate of mailed out surveys, compared by race/ethnicity and disease status [ Time Frame: 2025 ]
  • Response rate for saliva kits compared to survey response and determine if there is a disparity in participation between race/ethnic groups [ Time Frame: 2025 ]

Central Contacts and Locations

Central contacts

Luis Carvajal-Carmona, PhD

5307529654lgcarvajal@ucdavis.edu

Locations

University of California Davis Comprehensive Cancer Center

Recruiting

Sacramento, California, United States, 95817

Contacts

Luis Carvajal-Carmona, PhD

530-752-9654lgcarvajal@ucdavis.edu

More Information

Sponsor

University of California, Davis

Last update posted

Sep 25, 2025

Last verified

Sep, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, Davis on 2025-09-25.